iBio, Inc. financial data

Symbol
IBIO on Nasdaq
Location
New York, NY
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 10 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 511% % 138%
Quick Ratio 0% %
Debt-to-equity 23% % -62%
Return On Equity -71% % 28%
Return On Assets -58% % 6.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 34,543,561 shares 250%
Common Stock, Shares, Outstanding 30,053,070 shares 228%
Entity Public Float $22,429,069 USD 406%
Common Stock, Value, Issued $30,000 USD 233%
Weighted Average Number of Shares Outstanding, Basic 99,133,000 shares 986%
Weighted Average Number of Shares Outstanding, Diluted 99,133,000 shares 986%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $300,000 USD -100%
Research and Development Expense $12,960,000 USD 148%
General and Administrative Expense $12,813,000 USD 20%
Operating Income (Loss) $25,473,000 USD -64%
Nonoperating Income (Expense) $736,000 USD -44%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $24,737,000 USD -28%
Earnings Per Share, Basic -1.01 USD/shares -157%
Earnings Per Share, Diluted -1.01 USD/shares -157%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $28,672,000 USD 309%
Cash, Cash Equivalents, and Short-term Investments $6,431,000 USD -34%
Accounts Receivable, after Allowance for Credit Loss, Current $65,000 USD
Inventory, Net $0 USD
Assets, Current $53,368,000 USD 544%
Property, Plant and Equipment, Net $3,447,000 USD 1.7%
Operating Lease, Right-of-Use Asset $1,864,000 USD -16%
Intangible Assets, Net (Excluding Goodwill) $4,338,000 USD -29%
Assets $64,393,000 USD 197%
Accounts Payable, Current $2,654,000 USD 332%
Employee-related Liabilities, Current $876,000 USD -44%
Accrued Liabilities, Current $1,579,000 USD -14%
Contract with Customer, Liability, Current $1,150,000 USD 92%
Liabilities, Current $5,901,000 USD 25%
Operating Lease, Liability, Noncurrent $1,932,000 USD -21%
Liabilities $7,833,000 USD 0.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $10,000 USD
Retained Earnings (Accumulated Deficit) $346,937,000 USD -7.7%
Stockholders' Equity Attributable to Parent $56,560,000 USD 307%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $56,560,000 USD 307%
Liabilities and Equity $64,393,000 USD 197%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,665,000 USD -52%
Net Cash Provided by (Used in) Financing Activities $46,705,000 USD
Net Cash Provided by (Used in) Investing Activities $21,493,000 USD -3114%
Common Stock, Shares Authorized 275,000,000 shares 0%
Common Stock, Shares, Issued 30,053,070 shares 228%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $19,547,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28,900,000 USD 299%
Interest Paid, Excluding Capitalized Interest, Operating Activities $36,000 USD -37%
Deferred Tax Assets, Valuation Allowance $63,392,000 USD 16%
Depreciation $123,000 USD 2.5%
Payments to Acquire Property, Plant, and Equipment $32,000 USD
Lessee, Operating Lease, Liability, to be Paid $2,837,000 USD -19%
Property, Plant and Equipment, Gross $5,206,000 USD 12%
Operating Lease, Liability, Current $518,000 USD 12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $698,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $679,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.0725 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three $720,000 USD 3.2%
Deferred Tax Assets, Operating Loss Carryforwards $56,052,000 USD 14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $740,000 USD 2.8%
Operating Lease, Payments $141,000 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $20,000 USD 0%
Share-based Payment Arrangement, Expense $1,216,000 USD -26%
Interest Expense $52,000 USD 49%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%